An Insider’s Company Bought Altisource Shares

Brown’s Valley Development Company, which is owned by Altisource Portfolio Solutions S.A. (NASDAQ:ASPS) Board member Michael Linn, has purchased 1,000 shares of the company’s stock according to a filing with the SEC. The buy took place on November 27th, at an average price of $103.87 per share, and augments close to 16,000 shares that are owned by Linn, his children, and his trust. Altisource Portfolio Solutions S.A. is a mortgage portfolio management services company. The stock is up about 120% in the last year, and is up nearly 300% from two years ago, as investors see a recovery in the mortgage market and therefore good business for Altisource. Given that, it’s interesting to see further insider buys at the company. Normally insiders are incentivized to diversify their wealth away from the company, which is one reason why their purchases tend to outperform the market (here’s what studies say about insider trading), and we’d particularly expect people who have been long Altisource to lock in some of those profits rather than invest further. Instead, our database of insider filings shows that Linn has been adding shares over the last year, most recently in August (see a history of insider buys at Altisource).

OMEGA ADVISORS Leon Cooperman

Altisource Portfolio Solutions S.A.’s business has been doing well so far this year. In the first nine months of 2012, revenue grew 46% compared to the same period in 2011 and earnings were up 77% as SGA expenses rose only slightly. Growth rates were a bit slower in the third quarter, but net income was still up 57% from the third quarter of last year. The market seems only moderately bullish on the stock, as the trailing P/E multiple is 25; that’s fairly high compared to most stocks, but would indicate a much lower growth rate going forward. Wall Street analysts, meanwhile, are optimistic with the stock trading at 15 times consensus earnings for 2013 and a five-year PEG ratio of 0.4. Billionaire Leon Cooperman’s Omega Advisors cut its stake in Altisource by 20% during the third quarter, but still owned 1.3 million shares and it’s possible that the fund was locking in some of the profits on its investment. Omega had been a major investor for several quarters, and has generally been reducing the size of its position in small increments since early 2011. Check out billionaire Cooperman’s latest stock picks.

We would consider Fiserv, Inc. (NASDAQ:FISV), Lender Processing Services, Inc. (NYSE:LPS), Walter Investment Management Corp (NYSE:WAC), and Home Loan Servicing Solutions Ltd (NASDAQ:HLSS) to be a good peer group. These companies have a very wide range of trailing earnings multiples, but analyst expectations place them all in the 8x-13x range in terms of forward P/Es. So Altisource, on that basis, is more expensive than any of its peers and in some cases very much so. However, it appears that none of these other companies can match Altisource’s recent growth rate. Revenue, in many cases, shows little change in the company’s most recent quarter compared to the same period in the previous year. Earnings growth is better in some cases, with Lender Processing Services’s growth rate close to 45%, but that company is actually expected to see a higher growth rate going forward than Altisource judging by its higher trailing earnings multiple.

Continued insider purchases at the company, even after its rise, would seem to indicate strong confidence, and there’s a case to be made that based on analyst expectations Altisource remains undervalued. However, we’re puzzled as to how the company would be able to achieve and sustain a much faster earnings growth rate than its peers- which is necessary to justify its higher forward earnings multiple- and investors should confirm that this is likely before considering buying the stock.

Biotech Insider Alert - $6 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

The Oldest Money Managers

The Greatest Directors in the World

Largest Animals in the World

World’s Most Expensive Desserts

Best Selling Comic Books of All Time

A-list Actors who Sabotaged Their Career

Rappers With a College Degree

The Best Jazz Albums of all Time

The Most Influential Jazz Musicians

The World’s Most Famous Photographers

The Best Oscar-Winning Songs

Most Influential Choreographers Ever

Most Expensive Department Stores in the World

The Most Expensive Stolen Paintings in the World

The World’s Most Expensive Teas

Top Oscar Record Holders

The Most Expensive Flowers in the World

Countries With a Booming Film Industry

Most Expensive Cupcakes in the World

Uncommon European Escapes

The Most Stolen Artists in History

Best Travel Destinations in Australia

World’s Most Expensive Musical Instruments

World’s Most Famous Animals

Most Expensive Cakes in the World

Most Expensive Kosher Champagne in the World

Most Expensive Kosher Wine in the World

The Most Surprisingly Dark Fairy Tales

Most Popular Travel Destinations in Asia

The 10 Most Expensive Dresses Ever Worn to the Oscars

World’s Most Visited Art Museums

Best Countries for Photographers to Work in

Best Paid Jobs in the Film Industry

The Most Renowned Recovered Paintings Ever

Child Stars That Turned out Just Fine

Books That Were Banned in the Past Century

World’s Richest Dancers

Best Remedies against Bad Breath

Foods That Improve Your Skin Texture

Best-Selling Children’s Books of all Time

Foods That Boost Your Libido

Best-Selling Books of all Time

The Most Expensive Academy Awards Jewelry in History

Most Expensive Japanese Restaurant In New York City

The Best B-Boy Movies

Most Awesome Hip Hop Documentaries

Foods That Stain Your Teeth

Richest Doctors in the World

The Best Movie Sountracks Ever

The Highest Grossing Musicals on Broadway

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!